Committee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: 2005-2006 cycle
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 56.4% of dated attributable receipts.
Dominant category: Operations at 85.6% of spending.
Donor count
11
Contributions
12
Median
$2,750
Average
$3,222
Funding distribution
$5,000+
Count: 4
Share: 56.4%
Amount: $21,800
$1,000 - $4,999
Count: 6
Share: 41.4%
Amount: $16,025
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageMoney over time
Dated receipts only; unitemized reporting intervals are not allocated to dates.
Count: 1
Share: 1.4%
Amount: $550
$100 - $499
Count: 1
Share: 0.8%
Amount: $295
Spending categories
Operations
Amount: $35,422
Share: 85.6%
Consulting
Amount: $5,500
Share: 13.3%
Field
Amount: $440
Share: 1.1%
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| AMGEN | $5,600 | 14.5% | 1 | Jun 12, 2006 |
| GENENTECH | $5,600 | 14.5% | 1 | Apr 24, 2006 |
| GILEAD SCIENCES, INC. | $5,600 | 14.5% | 1 | Jul 27, 2006 |
| JOHNSON & JOHNSON | $5,600 | 14.5% | 2 | Apr 11, 2006 |
| LIGAND PHARMACEUTICALS | $5,000 | 12.9% | 1 | Feb 16, 2006 |
| PFIZER, INC. | $3,000 | 7.8% | 1 | May 8, 2006 |
| MERCK & CO., INC. | $2,750 | 7.1% | 1 | Mar 16, 2006 |
| NOVARTIS CORPORATION | $2,750 | 7.1% | 1 | May 31, 2006 |
| EDWARDS LIFESCIENCES | $1,925 | 5% | 1 | Feb 14, 2006 |
| AMYLIN PHARMACEUTICALS | $550 | 1.4% | 1 | May 23, 2006 |
| LELAND YEE FOR SENATE | $295 | 0.8% | 1 | Aug 11, 2006 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.